By Abigail Townsend
Date: Monday 23 Oct 2023
(Sharecast News) - Swiss drug giant Roche has agreed to buy Telavant Holdings from Pfizer and Roivant Sciences in a $7.1bn deal, it was announced on Monday.
No recent information was found.
Currency | US Dollars |
Share Price | $ 11.81 |
Change Today | $ 0.09 |
% Change | 0.77 % |
52 Week High | $12.71 |
52 Week Low | $9.26 |
Volume | 3,280,852 |
Time | Volume / Share Price |
16:00 | 408,869 @ $11.81 |
15:59 | 100 @ $11.82 |
15:59 | 132 @ $11.82 |
15:59 | 200 @ $11.82 |
15:59 | 200 @ $11.82 |
You are here: research